XML 38 R27.htm IDEA: XBRL DOCUMENT v3.22.2.2
Note 1 - Organization, Business and Financial Condition (Details)
$ in Thousands
Apr. 27, 2021
Sep. 30, 2022
USD ($)
Dec. 31, 2021
USD ($)
Sep. 30, 2021
USD ($)
Retained earnings (Accumulated deficit), ending balance   $ 105,200    
Cash and cash equivalents   $ 13,985 $ 10,495 $ 14,104
Reverse Stock Split [Member]        
Reverse stock split ratio 6      
Merger Agreement with Leading Biosciences, Inc. [Member]        
Merger agreement, exchange ratio 0.02719